We have collected information about Nonviral Gene Delivery And Therapeutics Targeting To Brain for you. Follow the links to find out details on Nonviral Gene Delivery And Therapeutics Targeting To Brain.
http://www.eurekaselect.com/73191/article
The nonviral nano-scaled gene delivery systems hold great promise for treating brain diseases due to their safety and convenience. Several brain targeting strategies, such as adsorptive- and receptor-mediated pathways have been developed to improve the brain targeting efficiency of non-viral gene delivery systems.Author: Yang Liu, Rongqin Huang, Chen Jiang
https://www.sciencedirect.com/science/article/pii/S1525001616309984
Nonviral vectors mediate transvascular delivery of siRNA and gene knockdown in vivo. ( a ) Naive mice ( n = 5) were injected intravenously with PBS (control) or biotinylated-C2-9r in PBS. The animals were sacrificed at indicated time points postinjection after which the brains were collected and postfixed.Author: Hayate Javed, Sindhu A Menon, Karima M Al-Mansoori, Abdelmojib Al-Wandi, Nour K Majbour, Mustafa T A...
http://adsabs.harvard.edu/abs/2011CNan....7...55L
ADS Classic is now deprecated. It will be completely retired in October 2019. This page will automatically redirect to the new ADS interface at that point.
https://n.neurology.org/content/62/8/1275
Apr 27, 2004 · Nonviral, noninvasive gene therapy of the brain is now possible with the development of a new approach to targeting therapeutic genes to the brain following an IV administration. This approach utilizes genetically engineered molecular Trojan horses, which ferry the gene across the BBB and into neurons.Author: Felix Schlachetzki, Yun Zhang, Ruben J. Boado, William M. Pardridge
https://www.cell.com/molecular-therapy-family/molecular-therapy/pdf/S1525-0016(16)30998-4.pdf
Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson’s Disease and Other Brain Disorders original article © The American Society of Gene & Cell Therapy Parkinson’s disease (PD) is a debilitating neurodegenera- …
https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30998-4
Apr 01, 2016 · Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders Parkinson's disease (PD) is a debilitating neurodegenerative disease characterized by tremor, rigidity, bradykinesia, and postural instability, for which there is no effective treatment available till date.Author: Hayate Javed, Sindhu A Menon, Karima M Al-Mansoori, Abdelmojib Al-Wandi, Nour K Majbour, Mustafa T A...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701689/
Oct 08, 2007 · 3. Delivery of protein therapeutics across the human blood-brain barrier with genetically engineered fusion proteins. The HIRMAb has been developed for brain drug targeting in humans, because the BBB transport activity of this MTH is nearly 10-fold greater than that of the TfRMAb . The murine HIRMAb cannot be used in humans.Author: William M. Pardridge
Searching for Nonviral Gene Delivery And Therapeutics Targeting To Brain?
You can just click the links above. The data is collected for you.
